These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
531 related articles for article (PubMed ID: 29981923)
61. Predictive Model for Drug-Induced Liver Injury Using Deep Neural Networks Based on Substructure Space. Kang MG; Kang NS Molecules; 2021 Dec; 26(24):. PubMed ID: 34946636 [TBL] [Abstract][Full Text] [Related]
62. Evaluation of DILI Predictive Hypotheses in Early Drug Development. Chan R; Benet LZ Chem Res Toxicol; 2017 Apr; 30(4):1017-1029. PubMed ID: 28257576 [TBL] [Abstract][Full Text] [Related]
63. A Computational Toxicology Approach to Screen the Hepatotoxic Ingredients in Traditional Chinese Medicines: He S; Zhang X; Lu S; Zhu T; Sun G; Sun X Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31591318 [TBL] [Abstract][Full Text] [Related]
64. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital. Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873 [TBL] [Abstract][Full Text] [Related]
65. Development of in silico prediction models for drug-induced liver malignant tumors based on the activity of molecular initiating events: Biologically interpretable features. Kurosaki K; Uesawa Y J Toxicol Sci; 2022; 47(3):89-98. PubMed ID: 35236804 [TBL] [Abstract][Full Text] [Related]
66. Dynamic imaging of adaptive stress response pathway activation for prediction of drug induced liver injury. Wink S; Hiemstra SW; Huppelschoten S; Klip JE; van de Water B Arch Toxicol; 2018 May; 92(5):1797-1814. PubMed ID: 29502165 [TBL] [Abstract][Full Text] [Related]
68. An In Silico Model for Predicting Drug-Induced Hepatotoxicity. He S; Ye T; Wang R; Zhang C; Zhang X; Sun G; Sun X Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 30999595 [TBL] [Abstract][Full Text] [Related]
69. In silico prediction of drug-induced liver injury with a complementary integration strategy based on hybrid representation. Gu Y; Wang Y; Wu Z; Li W; Liu G; Tang Y Mol Inform; 2023 Jul; 42(7):e2200284. PubMed ID: 37195875 [TBL] [Abstract][Full Text] [Related]
70. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Proctor WR; Foster AJ; Vogt J; Summers C; Middleton B; Pilling MA; Shienson D; Kijanska M; Ströbel S; Kelm JM; Morgan P; Messner S; Williams D Arch Toxicol; 2017 Aug; 91(8):2849-2863. PubMed ID: 28612260 [TBL] [Abstract][Full Text] [Related]
71. The in silico identification of human bile salt export pump (ABCB11) inhibitors associated with cholestatic drug-induced liver injury. Xi L; Yao J; Wei Y; Wu X; Yao X; Liu H; Li S Mol Biosyst; 2017 Jan; 13(2):417-424. PubMed ID: 28092392 [TBL] [Abstract][Full Text] [Related]
72. Development of novel tools for the in vitro investigation of drug-induced liver injury. Jiang J; Wolters JE; van Breda SG; Kleinjans JC; de Kok TM Expert Opin Drug Metab Toxicol; 2015; 11(10):1523-37. PubMed ID: 26155718 [TBL] [Abstract][Full Text] [Related]
73. [Clinical and pathological features in 138 cases of drug-induced liver injury]. Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136 [TBL] [Abstract][Full Text] [Related]
74. Comparative gene and protein expression analyses of a panel of cytokines in acute and chronic drug-induced liver injury in rats. Hanafusa H; Morikawa Y; Uehara T; Kaneto M; Ono A; Yamada H; Ohno Y; Urushidani T Toxicology; 2014 Oct; 324():43-54. PubMed ID: 25051504 [TBL] [Abstract][Full Text] [Related]
75. Quantitative targeted bile acid profiling as new markers for DILI in a model of methapyrilene-induced liver injury in rats. Slopianka M; Herrmann A; Pavkovic M; Ellinger-Ziegelbauer H; Ernst R; Mally A; Keck M; Riefke B Toxicology; 2017 Jul; 386():1-10. PubMed ID: 28529062 [TBL] [Abstract][Full Text] [Related]
76. Ensemble Models Based on QuBiLS-MAS Features and Shallow Learning for the Prediction of Drug-Induced Liver Toxicity: Improving Deep Learning and Traditional Approaches. Mora JR; Marrero-Ponce Y; García-Jacas CR; Suarez Causado A Chem Res Toxicol; 2020 Jul; 33(7):1855-1873. PubMed ID: 32406679 [TBL] [Abstract][Full Text] [Related]
77. Activation of the Nrf2 response by intrinsic hepatotoxic drugs correlates with suppression of NF-κB activation and sensitizes toward TNFα-induced cytotoxicity. Herpers B; Wink S; Fredriksson L; Di Z; Hendriks G; Vrieling H; de Bont H; van de Water B Arch Toxicol; 2016 May; 90(5):1163-79. PubMed ID: 26026609 [TBL] [Abstract][Full Text] [Related]
78. An entropy weight method to integrate big omics and mechanistically evaluate DILI. Jin Y; Shou Y; Lei Q; Du C; Xu L; Chen N; Ma W; Zhu X; Zhou S; Zheng Y; Yu D Hepatology; 2024 Jun; 79(6):1264-1278. PubMed ID: 37820269 [TBL] [Abstract][Full Text] [Related]
79. Clinical Features of Drug-induced Liver Injury According to Etiology. Lee BM; Lee WC; Jang JY; Ahn P; Kim JN; Jeong SW; Park EJ; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS J Korean Med Sci; 2015 Dec; 30(12):1815-20. PubMed ID: 26713057 [TBL] [Abstract][Full Text] [Related]
80. Prediction of drug induced liver injury using molecular and biological descriptors. Muller C; Pekthong D; Alexandre E; Marcou G; Horvath D; Richert L; Varnek A Comb Chem High Throughput Screen; 2015; 18(3):315-22. PubMed ID: 25747442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]